Get all your news in one place.
100's of premium titles.
One app.
Start reading
Fortune
Fortune
Steve Mollman

EXPLAINED: An experimental cancer trial in france is getting a boost from the gates foundation potential game changer | Vintage Vibes

Marina Cavazzana (Credit: Stephane GRANGIER—Corbis via Getty Images)

The Bill & Melinda Gates Foundation is known for spending billions to fight infectious diseases in developing countries, so a new investment in a French biotech company feels somewhat unusual.

Smart Immune will receive $5 million from the foundation, according to the Financial Times. The company has developed a thymus-empowered T-cell therapy platform, called ProTcell, “to fully and rapidly re-arm the immune system.”

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.